Track the Canadian Junior Mining Market at the speed of AI

Build a portfolio of Canadian junior mining companies on 6ix and get real-time updates the minute they announce something. Discover investor events, company profiles, and news in one place.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
11m ago	Mountain Valley MD Advances Quicksome™ Sublingual Delivery Platform for Compounded Peptide Applications, Reports on Initial Formulation Work Across Multiple Peptides Including BPC-157 Mountain Valley Md Holdings Inc
11m ago	New TECVAYLI®▼ (teclistamab) data demonstrate superior progression-free and overall survival versus standard of care as early as first relapse in multiple myeloma Johnson & Johnson
12m ago	Moleculin Presents ASCO 2026 Data Demonstrating No Detectable Cardiotoxicity with Annamycin Despite Exposure Levels Far Exceeding Conventional Anthracycline Limits Moleculin Biotech, Inc.
12m ago	New TECVAYLI® (teclistamab-cqyv) data demonstrate superior progression-free and overall survival as early as first relapse in multiple myeloma Johnson & Johnson
12m ago	MidOcean Partners Signs Definitive Agreement to Sell Zonda to CoStar Group Costar Group, Inc.

About

0.74USD+0.15 +26.39%

Closed • Updated at 12:53 GMT+00:00

Market Cap$89.44M

Volume107.38M

Beta2.39

RSI85.79

Health TechnologyPharmaceuticals: Major

Outlook Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Sapu Nano Unveils Progress in Deciparticle™ Nanomedicine Platform and AI-Driven Oncology Development at BIO 2026

Outlook Therapeutics Wins Appeal Following Formal Dispute Resolution Process for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Outlook Therapeutics Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

Recent Videos

OTLK Stock Next WEEK CRAZY!? (Urgent: Thank Me Later) Outlook Therapeutics stock best broker review

OTLK Stock Next WEEK CRAZY!? (Urgent: Thank Me Later) Outlook Therapeutics stock best broker review

May 28, 2026

60-Day Countdown:OTLK Stock Just Got a Massive FDA Green Light!🚀 OTLK STOCK ANALYSIS PODCAST TODAY

60-Day Countdown:OTLK Stock Just Got a Massive FDA Green Light!🚀 OTLK STOCK ANALYSIS PODCAST TODAY

May 28, 2026

Outlook Therapeutics Surges 35% Pre-Market After FDA Dispute Win (ONS-5010)

Outlook Therapeutics Surges 35% Pre-Market After FDA Dispute Win (ONS-5010)

May 28, 2026

Outlook Therapeutics Surges 35% Pre-Market After FDA Dispute Win (ONS-5010)

Outlook Therapeutics Surges 35% Pre-Market After FDA Dispute Win (ONS-5010)

May 28, 2026

Community Chat

Ask AI

Try asking